Staar Surgical shares advanced Friday after the company said its board authorized a $50 million share-buyback program.
Shares rose 6.3% to $20.27.
The vision-correction solutions company said the decision was based on the board's confidence in its business progress, as well as its strong balance sheet and free-cash-flow levels.
Shares have been under pressure in 2026, down about 12% since the start of the year including the day's trading. The stock is down 24% over the last 52 weeks.
The company currently has $181.5 million in liquidity to use towards the repurchases, it said.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments